Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Genentech
Ligand Pharmaceuticals
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT01116622
First received: April 14, 2010
Last updated: August 2, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)